The beige mouse model for mycobacterium avium complex (MAC) disease: Optimal conditions for the host and parasite
- 1 December 1989
- Vol. 70 (4) , 257-271
- https://doi.org/10.1016/0041-3879(89)90020-2
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Susceptibility of Beige Mice toMycobacterium aviumComplex Infections by Different Routes of ChallengeAmerican Review of Respiratory Disease, 1989
- In vivo activity of amikacin alone or in combination with clofazimine or rifabutin or both against acute experimental Mycobacterium avium complex infections in beige miceAntimicrobial Agents and Chemotherapy, 1988
- Association of Plasmids and Virulence ofMycobacterium aviumComplexAmerican Review of Respiratory Disease, 1988
- Activity of Rifabutin Alone or in Combination with Clofazimine or Ethambutol or Both Against Acute and Chronic ExperimentalMycobacterium intracellulareInfectionsAmerican Review of Respiratory Disease, 1987
- Beige mouse as a suitable experimental animal model for acquired immune deficiency syndrome (AIDS)International Journal of Immunopharmacology, 1985
- An Acute Infection Model forMycobacterium intracellulareDisease Using Beige Mice: Preliminary Results1,2American Review of Respiratory Disease, 1983
- Mycobacterium avium-intracellulare: A Cause of Disseminated Life-Threatening Infection in Homosexuals and Drug AbusersAnnals of Internal Medicine, 1982
- Immune Responses to Atypical Mycobacterial Lung InfectionsClinical Infectious Diseases, 1981
- Experimental Infections with Mycobacterium intracellulareClinical Infectious Diseases, 1981
- The Difference in Response of Four Strains of Mice to Immunization Against Tuberculous Infection1American Review of Respiratory Disease, 1959